New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 9, 2014
09:11 EDTYRCW, SQNM, BIIB, SGMO, MCK, ROVI, QIHU, BBBY, DG, FDO, ICPT, JCP, MOn The Fly: Pre-market Movers
HIGHER: Macy's (M), up 6% after announcing cost reduction initiatives that include cutting 2,500 jobs and issuing FY14 EPS guidance that beat the consensus analyst estimate... Intercept (ICPT), up over 200% after announcing NASH primary endpoint met, FLINT trial stopped early... J.C. Penney (JCP), up 3% after upgraded at Piper Jaffray... McKesson (MCK), up 3.7% after making final offer for Celesio, increases price to EUR 23.50 per share... Sangamo (SGMO), up 14.3% after collaborating with Biogen (BIIB) for hemoglobinopathy treatment development... Sequenom (SQNM), up 10.6% after granted patent by European patent office... DOWN AFTER EARNINGS: Family Dollar (FDO), down 7.3%. Peer Dollar General (DG) down 2.4% in sympathy... Bed Bath & Beyond (BBBY), down 9%... Rovi (ROVI), down 3.4%. ALSO LOWER: Qihoo 360 (QIHU), down 4.5% after China Daily reported the company denied Alibaba's interested in investing... YRC Worldwide (YRCW), down 13% after Teamsters group says union contract extension may be defeated.
News For M;JCP;ICPT;FDO;DG;BBBY;QIHU;ROVI;MCK;SGMO;BIIB;SQNM;YRCW From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
October 8, 2014
10:25 EDTJCPJ.C. Penney says home is $750M growth opportunity
Subscribe for More Information
10:00 EDTMCKOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:23 EDTMCitigroup to hold a tour
Athletic Footwear Mall Tour travels to Roosevelt Field Mall, Garden City, New York on October 8.
09:20 EDTJCPJ.C. Penney says will expand Disney stops in stores to 680 from 500
09:20 EDTJCPJ.C. Penney CEOsays will open more Sephora shops in store
Subscribe for More Information
09:20 EDTJCP, ICPTOn The Fly: Pre-market Movers
Subscribe for More Information
08:18 EDTJCPJ.C. Penney CEO Ullman says customers remain cautious
Subscribe for More Information
07:05 EDTICPTIntercept says FLINT trial NASH data will not be presented at AASLD
Intercept Pharmaceuticals announced upcoming presentations of data at the upcoming American Academy for the Study of Liver Diseases, or AASLD, Annual Meeting, being held in Boston, Massachusetts from November 7-11. Obeticholic acid, or OCA, Intercept's lead product candidate, is a bile acid analog and first-in-class agonist of the farnesoid X receptor in development for primary biliary cirrhosis, nonalcoholic steatohepatitis, primary sclerosing cholangitis and other chronic liver and intestinal diseases. CEO Mark Pruzanski said, "We are pleased that several key abstracts from Intercept's Phase 3 program for OCA in PBC will be presented at AASLD. With respect to the NIDDK-sponsored FLINT trial of OCA in NASH, we have learned that the NASH CRN has decided to focus on finalizing the manuscript intended for near term publication in lieu of presentation at AASLD. We are reaffirming the previously reported top-line results based on a revised draft manuscript that our partners at NIDDK have provided us. We believe that peer reviewed publication of the FLINT data will mark another important milestone supportive of OCA's potential as a novel therapy for patients with NASH and associated liver fibrosis. In the meantime, we continue preparing for the initiation of our Phase 3 NASH program in the first half of 2015."
06:16 EDTMCKMcKesson initiated with a Buy at Citigroup
Target $235.
October 7, 2014
13:04 EDTJCPJ.C. Penney to host analyst day
Subscribe for More Information
10:57 EDTBBBYBed Bath and Beyond calls active on renewed activist investor speculation
Subscribe for More Information
10:43 EDTBBBYRumor: Bed Bath & Beyond moves up on renewed activist investor speculation
10:18 EDTSQNMHigh option volume stocks
Subscribe for More Information
10:13 EDTJCPJ.C. Penney volatility increases into company hosted analyst day
J.C. Penney October weekly call option implied volatility is at 118, October is at 72, November is at 57, January is at 55, February is at 53; compared to its 26-week average of 54 according to Track Data suggesting large near term price movement into a company hosted analyst day event on October 8.
10:02 EDTICPTOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:39 EDTMMacy's Q3 revenues tracking to $6.25B vs. consensus $6.392B, says ITG Research
Subscribe for More Information
09:24 EDTSQNMMaxim recommends buying Sequenom
Subscribe for More Information
09:01 EDTSQNMSequenom acquisition a strategic positive, says Maxim
Subscribe for More Information
07:32 EDTICPTIntercept initiated with an Outperform at JMP Securities
Subscribe for More Information
07:24 EDTBIIB, SGMOAlliance for Regenerative Medicine
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use